Symbol="MORF"
AssetType="Common Stock"
Name="Morphic Holding Inc"
Description="Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1679363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE A2, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2646869000"
EBITDA="-69930000"
PERatio="None"
PEGRatio="None"
BookValue="10.76"
DividendPerShare="0"
DividendYield="0"
EPS="-1.65"
RevenuePerShareTTM="1.774"
ProfitMargin="-0.924"
OperatingMarginTTM="-1.029"
ReturnOnAssetsTTM="-0.106"
ReturnOnEquityTTM="-0.172"
RevenueTTM="68947000"
GrossProfitTTM="-31254000"
DilutedEPSTTM="-1.65"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="73.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.03"
PriceToBookRatio="2.901"
EVToRevenue="9.32"
EVToEBITDA="-12.06"
Beta="1.104"
num_52WeekHigh="63.08"
num_52WeekLow="23.02"
num_50DayMovingAverage="57.24"
num_200DayMovingAverage="38.9"
SharesOutstanding="45825300"
DividendDate="None"
ExDividendDate="None"
symbol="MORF"
open="58.41"
high="58.60"
low="57.40"
price="58.35"
volume="325089.00"
latest_trading_day="2023-07-12"
previous_close="57.76"
change="0.59"
change_percent="1.0215%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="556448"
Change_recent_avg="0.03"
Delta_recent_avg="2.47"
Variance_recent_avg="1.23"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0041.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="537"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="965"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
